Test Price
2,800 AED✅ Home Collection Available
IFIH1 Gene Aicardi-Goutières Syndrome Type 7 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
This genetic test confirms diagnosis of Aicardi-Goutières syndrome type 7 through high-coverage next-generation sequencing of the IFIH1 gene, achieving 99.9% diagnostic sensitivity. The service includes ISO-certified cold-chain specimen logistics, post-test telephonic counselling, and direct insurance verification. A mandatory pre-test genetic counselling session is required before sample collection in compliance with DHA genetic testing standards.
Test Overview & Methodology
This next-generation sequencing (NGS) test screens the entire coding region and splice-site boundaries of the IFIH1 gene to detect pathogenic single-nucleotide variants, small insertions and deletions, and copy-number alterations responsible for Aicardi-Goutières syndrome type 7. The assay achieves >99% detection rate for known pathogenic variants and includes Sanger confirmation for all clinically significant findings. Testing is performed on peripheral whole blood, extracted DNA, or dried blood spot specimens processed under ISO 9001:2015 certified workflows.
| Feature | Our Test (IFIH1 NGS Panel) | Closest Alternative (Single Exon Sanger) |
|---|---|---|
| Methodology | NGS with CNV analysis & Sanger confirmation | Targeted PCR + Sanger of one exon |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Diagnostic Yield | >99% of known pathogenic variants | <70% (misses deep intronic/CNVs) |
| Price (AED) | 2800 | 3200+ |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics, I understand the profound uncertainty families experience when facing a potential diagnosis of Aicardi-Goutières syndrome. A pathogenic variant in the IFIH1 gene must always be interpreted alongside clinical presentation, neuroimaging data, and family history. Pre‑ and post‑test genetic counselling is essential; never evaluate these results in isolation. Our multidisciplinary team is here to support you at every stage of this diagnostic journey."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory – Medication Safety Precautions
Medication Safety Notice
Do not discontinue prescribed medication without consulting your doctor. This genetic test does not replace clinical management; always follow your physician's advice regarding treatment decisions.
Exclusion Criteria & Urgent Care Indicators
- Acute febrile illness or uncontrolled systemic infection at time of sampling.
- Known coagulopathy or use of anticoagulants without medical clearance for venipuncture.
- If the patient is under 18, written parental consent is mandatory in compliance with UAE child protection regulations.
- Seek immediate emergency care if the patient develops seizures, respiratory distress, or altered consciousness — these are not contraindications of the test but may indicate disease progression requiring urgent medical intervention.
Patient FAQ & Clinical Guidance
1. What does the IFIH1 gene test diagnose?
This genetic test sequences the IFIH1 gene using next-generation technology to confirm a diagnosis of Aicardi-Goutières syndrome type 7, a rare early-onset interferonopathy characterised by severe neurological involvement. It identifies single-nucleotide variants, small insertions and deletions, and copy-number changes with high coverage, ensuring detection of known pathogenic mutations responsible for encephalopathy and immune dysregulation.
2. How long does it take to receive results and what are the sample requirements?
Results are delivered within 3 to 4 weeks after the laboratory receives whole blood, extracted DNA, or dried blood spot. The specimen undergoes ISO‑certified temperature‑controlled cold‑chain transport. You can schedule a VIP mobile phlebotomy home visit between 8 AM and 11 PM daily. A mandatory pre‑test genetic counselling session must be completed before sample collection, including a pedigree chart of affected family members, in compliance with DHA genetic testing standards.
3. Is this test covered by health insurance in the UAE?
Most UAE health insurers cover genetic testing for Aicardi-Goutières syndrome when pre‑authorised by a neurologist or clinical geneticist. We verify your coverage directly via WhatsApp at +971 54 548 8731 before scheduling and provide a detailed medical necessity letter if required. Direct billing arrangements are available for participating insurance networks.
UAE Regulatory & Data Privacy Adherence
This service operates under DHA Facility License Number 1143 and complies with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is processed with strict confidentiality on secure, audited infrastructure. ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | IFIH1 Gene Aicardi-Goutières Syndrome Type 7 Genetic Test (NGS) |
| Price (AED) | 2800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood, extracted DNA, or dried blood spot |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV analysis & Sanger confirmation |
| ICD-10-CM Code | G04.1 |
| LOINC Code | 81304-0 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians